- Learning Objective 1: To understand how peptide therapeutics may overcome a significant druggability gap against cancer.
- Learning Objective 2: How to extend the therapeutic window of drugs used to induce cell death in patients.
- Learning Objective 3: To better understand challenges to drugging intracellular protein: protein interactions.
03/24/2022 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
James LaBelle, MD, PhD